Effects of diet on genetic regulation of lipoprotein metabolism in baboons

Atherosclerosis

Volumn 213, Issue 2, 2010, Pages 499-504

  Rainwater, David L ^a   VandeBerg, John L ^a,b   Mahaney, Michael C ^a,b  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b SOUTHWEST NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

Dietary cholesterol; Dietary fat; Genetic correlation; Primate

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; FAT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ARTICLE; BABOON; BIVARIATE ANALYSIS; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIETARY INTAKE; FAT INTAKE; GENE REGULATORY NETWORK; GENETIC ANALYSIS; LIPOPROTEIN METABOLISM; NONHUMAN; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL;

ANIMALS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; CARDIOVASCULAR DISEASES; CHOLESTEROL, DIETARY; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY FATS; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; LIPOPROTEINS; MALE; PAPIO;

EID: 78649721119     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.08.079     Document Type: Article

References (37)

1. Bossé Y., Pérusse L., Vohl M.-C. Genetics of LDL particle heterogeneity: from genetic epidemiology to DNA-based variations. J Lipid Res 2004, 45:1008-1026.
2. Sviridov D., Nestel P.J. Genetic factors affecting HDL levels, structure, metabolism and function. Curr Opin Lipidol 2007, 18:157-163.
3. Kathiresan S., Musunuru K., Orho-Melander M. Defining the spectrum of alleles that contribute to blood lipid concentrations in humans. Curr Opin Lipidol 2008, 19:122-127.
4. Holleboom A.G., Vergeer M., Hovingh G.K., Kastelein J.J., Kuivenhoven J.A. The value of HDL genetics. Curr Opin Lipidol 2008, 19:385-394.
5. Rainwater D.L., VandeBerg J.L. Baboon model for dyslipidemia and atherosclerosis. The baboon in biomedical research 2009, 225-236. Springer, New York. J.L. VandeBerg, S. Williams-Blangero, S.D. Tardiff (Eds.).
6. Kushwaha R.S, McGill H.C. Diet, plasma lipoproteins and experimental atherosclerosis in baboons (Papio sp.). Hum Reprod Update 1998, 4:420-429.
7. Rainwater D.L., Cox L.A., Rogers J., VandeBerg J.L., Mahaney M.C. Localization of multiple pleiotropic genes for lipoprotein metabolism in baboons. J Lipid Res 2009, 50:1420-1428.
8. Wang X.L., Rainwater D.L., Mahaney M.C., Stocker R. Cosupplementation with vitamin E and coenzyme Q10 reduces circulating markers of inflammation in baboons. Am J Clin Nutr 2004, 80:649-655.
9. Cheng M.-L., Woodford S.C., Hilburn J.L., VandeBerg J.L. A novel system for storage of sera frozen in small aliquots. J Biochem Biophys Methods 1986, 13:47-51.
10. Rainwater D.L., Kammerer C.M., Carey K.D., et al. Genetic determination of HDL variation and response to diet in baboons. Atherosclerosis 2002, 161:335-343.
11. Lipid Research Clinics Program Manual of laboratory operations, volume 1: lipid and lipoprotein analysis (DHEW Publ. No. (NIH) 75-628) 1974, U.S. Government Printing Office, Washington, DC, 56 pp.
12. Cheng M.-L., Kammerer C.M., Lowe W.F., Dyke B., VandeBerg J.L. Method for quantitating cholesterol in subfractions of serum lipoproteins separated by gradient gel electrophoresis. Biochem Genet 1988, 26:657-681.
13. Rainwater D.L., Moore P.H., Shelledy W.R., Dyer T.D., Slifer S.H. Characterization of a composite gradient gel for the electrophoretic separation of lipoproteins. J Lipid Res 1997, 38:1261-1266.
14. Rainwater D.L., Moore P.H., Gamboa I.O. Improved method for making nondenaturing composite gradient gels for the electrophoretic separation of lipoproteins. J Lipid Res 2004, 45:773-775.
15. Rainwater D.L., Kammerer C.M., Cox L.A., et al. A major gene influences variation in large HDL particles and their response to diet in baboons. Atherosclerosis 2002, 163:241-248.
16. Kammerer C.M., Rainwater D.L., Cox L.A., et al. Locus controlling LDL cholesterol response to dietary cholesterol is on baboon homologue of human chromosome 6. Arterioscler Thromb Vasc Biol 2002, 22:1720-1725.
17. Almasy L., Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998, 62:1198-1211.
18. Mahaney M.C., Blangero J., Rainwater D.L., et al. Pleiotropy and genotype by diet interaction in a baboon model for atherosclerosis-a multivariate quantitative genetic analysis of HDL subfractions in two dietary environments. Arterioscler Thromb Vasc Biol 1999, 19:1134-1141.
19. Gofman J.W., Glazier F., Tamplin A., Strisower B., De Lalla O. Lipoproteins, coronary heart disease, and atherosclerosis. Physiol Rev 1954, 34:589-607.
20. Vaisar T., Pennathur S., Green P.S., et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest 2007, 117:746-756.
21. Davidson W.S., Silva R.A.G.D., Chantepie S., et al. Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function. Arterioscler Thromb Vasc Biol 2009, 29:870-876.
22. LaRosa J.C., Hunninghake D., Bush D., et al. The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association. Circulation 1990, 81:1721-1733.
23. Contois J.H., McConnell J.P., Sethi A.A., et al. Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices. Clin Chem 2009, 55:407-419.
24. Thompson A., Danesh J. Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies. J Intern Med 2006, 259:481-492.
25. Otvos J.D., Collins D., Freedman D.S., et al. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial. Circulation 2006, 113:1556-1563.
26. Gardner C.D., Fortmann S.P., Krauss R.M. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996, 276:875-881.
27. Stampfer M.J., Krauss R.M., Ma J., et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996, 276:882-888.
28. Lamarche B., Tchernof A., Moorjani S., et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 1997, 95:69-75.
29. Campos H., Moye L.A., Glasser S.P., Stampfer M.J., Sacks F.M. Low-density lipoprotein size, pravastatin treatment, and coronary events. JAMA 2001, 286:1468-1474.
30. Arsenault B.J., Lemieux I., Despres J.P., et al. HDL particle size and the risk of coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Atherosclerosis 2009, 206:276-281.
31. Sacks F.M., Campos H. Clinical review 163: Cardiovascular endocrinology: low-density lipoprotein size and cardiovascular disease: a reappraisal. J Clin Endocrinol Metab 2003, 88:4525-4532.
32. Musunuru K., Orho-Melander M., Caulfield M.P., et al. Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk. Arterioscler Thromb Vasc Biol 2009, 29:1975-1980.
33. Vinson A., Mahaney M.C., Diego V.P., et al. Genotype-by-diet effects on co-variation in Lp-PLA2 activity and LDL cholesterol concentration in baboons fed an atherogenic diet. J Lipid Res 2008, 49:1295-1302.
34. Edwards K.L., Mahaney M.C., Motulsky A.G., Austin M.A. Pleiotropic genetic effects on LDL size, plasma, triglyceride, and HDL cholesterol in families. Arterioscler Thromb Vasc Biol 1999, 19:2456-2464.
35. Hokanson J.E., Langefeld C.D., Mitchell B.D., et al. Pleiotropy and heterogeneity in the expression of atherogenic lipoproteins: the IRAS Family Study. Hum Hered 2003, 55:46-50.
36. Kullo I.J., de Andrade M., Boerwinkle E., et al. Pleiotropic genetic effects contribute to the correlation between HDL cholesterol, triglycerides, and LDL particle size in hypertensive sibships. Am J Hypertens 2005, 18:99-103.
37. Vinson A., Mahaney M.C., Cox L.A., et al. A pleiotropic QTL on 2p influences serum Lp-PLA2 activity and LDL cholesterol concentration in a baboon model for the genetics of atherosclerosis risk factors. Atherosclerosis 2008, 196:667-673.